Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Presses FDA To Speak Up On OTC/Supplement Combo Products

This article was originally published in The Tan Sheet

Executive Summary

Congressional interest turns up the pressure on FDA to make a statement on Bayer Aspirin with Heart Advantage, and issue a definitive policy on any products that combine dietary supplement and OTC drug ingredients

You may also be interested in...



US FDA Suggests Adding Antioxidants To Drug Formulations To Mitigate Nitrosamine Risks

Agency recommends “mitigation strategies” also including designing formulations that incorporate excipients such as sodium carbonate which modify the micro-environment to neutral or basic pH.

Bayer Reboots Heart Advantage With Promotion For Aspirin

Bayer is using the reformulation of its Bayer Heart Health Advantage cholesterol-lowering phytosterol supplement as an opportunity to cross-promote with its aspirin brand

Bayer Reboots Heart Advantage With Promotion For Aspirin

Bayer is using the reformulation of its Bayer Heart Health Advantage cholesterol-lowering phytosterol supplement as an opportunity to cross-promote with its aspirin brand

Related Content

Topics

UsernamePublicRestriction

Register

PS102208

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel